A citation-based method for searching scientific literature

Makoto Kagawa, Satoru Kawakami, Azusa Yamamoto, Okihide Suzuki, Hidetaka Eguchi, Yasushi Okazaki, Kiwamu Akagi, Jun-Ichi Tamaru, Tomio Arai, Tatsuro Yamaguchi, Hideyuki Ishida. Jpn J Clin Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.
Masakazu Kohda, Kensuke Kumamoto, Hidetaka Eguchi, Tomoko Hirata, Yuhki Tada, Kohji Tanakaya, Kiwamu Akagi, Seiichi Takenoshita, Takeo Iwama, Hideyuki Ishida,[...]. Fam Cancer 2016
13
100

Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Tetsuya Ito, Koji Kono, Hidetaka Eguchi, Yasushi Okazaki, Gou Yamamoto, Tetsuhiko Tachikawa, Kiwamu Akagi, Yohei Okada, Satoru Kawakami, Makoto Morozumi,[...]. Jpn J Clin Oncol 2020
8
100

Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
Jennifer Y Ju, Anne M Mills, Mani S Mahadevan, Jinbo Fan, Stephen H Culp, Martha H Thomas, Helen P Cathro. Am J Surg Pathol 2018
23
100

Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
Jinru Shia, Laura H Tang, Efsevia Vakiani, Jose G Guillem, Zsofia K Stadler, Robert A Soslow, Nora Katabi, Martin R Weiser, Philip B Paty, Larissa K Temple,[...]. Am J Surg Pathol 2009
118
100


Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Jaclyn C Watkins, Eric J Yang, Michael G Muto, Colleen M Feltmate, Ross S Berkowitz, Neil S Horowitz, Sapna Syngal, Matthew B Yurgelun, Anu Chittenden, Jason L Hornick,[...]. Int J Gynecol Pathol 2017
55
100

The 2004 WHO classification of bladder tumors: a summary and commentary.
Rodolfo Montironi, Antonio Lopez-Beltran. Int J Surg Pathol 2005
159
100

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
James W F Catto, George Xinarianos, Julian L Burton, Mark Meuth, Freddie C Hamdy. Int J Cancer 2003
68
100

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.
Henry T Lynch, C Richard Boland, Gordon Gong, Trudy G Shaw, Patrick M Lynch, Riccardo Fodde, Jane F Lynch, Albert de la Chapelle. Eur J Hum Genet 2006
101
100

Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Lucía Pérez-Carbonell, Clara Ruiz-Ponte, Carla Guarinos, Cristina Alenda, Artemio Payá, Alejandro Brea, Cecilia M Egoavil, Adela Castillejo, Victor M Barberá, Xavier Bessa,[...]. Gut 2012
134
100

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.
Shuji Ogino, Takako Kawasaki, Mohan Brahmandam, Mami Cantor, Gregory J Kirkner, Donna Spiegelman, G Mike Makrigiorgos, Daniel J Weisenberger, Peter W Laird, Massimo Loda,[...]. J Mol Diagn 2006
324
100


The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.
Tetsuya Ito, Tatsuro Yamaguchi, Tomokazu Wakatsuki, Tsuyoshi Suzuki, Hidetaka Eguchi, Yasushi Okazaki, Gou Yamamoto, Tetsuhiko Tachikawa, Satoru Kawakami, Astushi Sasaki,[...]. Jpn J Clin Oncol 2019
6
100

Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Roland P Kuiper, Lisenka E L M Vissers, Ramprasath Venkatachalam, Danielle Bodmer, Eveline Hoenselaar, Monique Goossens, Aline Haufe, Eveline Kamping, Renée C Niessen, Frans B L Hogervorst,[...]. Hum Mutat 2011
101
100

Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Sean C Skeldon, Kara Semotiuk, Melyssa Aronson, Spring Holter, Steven Gallinger, Aaron Pollett, Cynthia Kuk, Bas van Rhijn, Peter Bostrom, Zane Cohen,[...]. Eur Urol 2013
58
100

Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.
Angela N Bartley, Rajyalakshmi Luthra, Devki S Saraiya, Diana L Urbauer, Russell R Broaddus. Cancer Prev Res (Phila) 2012
76
100

63
100

Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer.
K Ericson, B Halvarsson, J Nagel, E Rambech, M Planck, Z Piotrowska, H Olsson, M Nilbert. Eur J Cancer 2003
24
100

Prevalence and Molecular Characterization of Defective DNA Mismatch Repair in Small-bowel Carcinoma in a Japanese Hospital-based Population.
Tetsuya Ito, Hideyuki Ishida, Okihide Suzuki, Noriyasu Chika, Kunihiko Amano, Keiichiro Ishibashi, Nao Kamae, Yuhki Tada, Kiwamu Akagi, Hidetaka Eguchi,[...]. J Anus Rectum Colon 2020
1
100

Genetic analysis of hMLH1 in transitional cell carcinoma of the urinary tract: promoter methylation or mutation.
M Furihata, T Takeuchi, Y Ohtsuki, N Terao, M Kuwahara, T Shuin. J Urol 2001
15
100

Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.
Tatsuro Yamaguchi, Yoichi Furukawa, Yusuke Nakamura, Nagahide Matsubara, Hideki Ishikawa, Masami Arai, Naohiro Tomita, Kazuo Tamura, Kokichi Sugano, Chikashi Ishioka,[...]. Jpn J Clin Oncol 2015
24
100

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
176
100

Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer.
Maximilian Burger, Sarah J Burger, Stefan Denzinger, Peter J Wild, Wolf F Wieland, Hagen Blaszyk, Ellen C Obermann, Robert Stoehr, Arndt Hartmann. Eur Urol 2006
24
100

Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study.
Ekaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K Liu, Danny Vesprini, Jane Bayani, John Bartlett, Bin Xu, Michelle R Downes. J Clin Pathol 2021
3
100

Tumor development in Japanese patients with Lynch syndrome.
Chiaki Saita, Tatsuro Yamaguchi, Shin-Ichiro Horiguchi, Rin Yamada, Misato Takao, Takeru Iijima, Rika Wakaume, Tomoyuki Aruga, Taku Tabata, Koichi Koizumi. PLoS One 2018
14
100

Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population.
Yusuke Tajima, Hidetaka Eguchi, Noriyasu Chika, Tomonori Nagai, Sariya Dechamethakun, Kensuke Kumamoto, Tetsuhiko Tachikawa, Kiwamu Akagi, Jun-Ichi Tamaru, Hiroyuki Seki,[...]. Jpn J Clin Oncol 2018
4
100

Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.
Amanda S Bruegl, Kari L Ring, Molly Daniels, Bryan M Fellman, Diana L Urbauer, Russell R Broaddus. Cancer Prev Res (Phila) 2017
32
100

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).
H F A Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, G Capella, C Engel, I Frayling,[...]. J Med Genet 2007
359
100

Clinical relevance of microsatellite instability in colorectal cancer.
Albert de la Chapelle, Heather Hampel. J Clin Oncol 2010
188
100

Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency.
Jinru Shia, Liying Zhang, Moshe Shike, Min Guo, Zsofia Stadler, Xiaoling Xiong, Laura H Tang, Efsevia Vakiani, Nora Katabi, Hangjun Wang,[...]. Mod Pathol 2013
53
100

Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.
Azusa Yamamoto, Tatsuro Yamaguchi, Okihide Suzuki, Tetsuya Ito, Noriyasu Chika, Nao Kamae, Jun-Ichi Tamaru, Tomonori Nagai, Hiroyuki Seki, Tomio Arai,[...]. Jpn J Clin Oncol 2021
3
100

Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based population.
Kouki Kuwabara, Okihide Suzuki, Noriyasu Chika, Kensuke Kumamoto, Toshiharu Minabe, Tomoo Fukuda, Eiichi Arai, Jun-Ichi Tamaru, Kiwamu Akagi, Hidetaka Eguchi,[...]. Jpn J Clin Oncol 2018
8
100

Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population.
Noriyasu Chika, Hidetaka Eguchi, Kensuke Kumamoto, Okihide Suzuki, Keiichiro Ishibashi, Tetsuhiko Tachikawa, Kiwamu Akagi, Jun-Ichi Tamaru, Yasushi Okazaki, Hideyuki Ishida. Jpn J Clin Oncol 2017
29
100

Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder.
Anjelica Hodgson, Danny Vesprini, Stanley K Liu, Bin Xu, Michelle R Downes. J Clin Pathol 2020
1
100

Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.
Noriko Fukuhara, Tomohiro Kinoshita, Kazuhito Yamamoto, Hirokazu Nagai, Koji Izutsu, Go Yamamoto, Pankaj Bhargava, Nishan Rajakumaraswamy, Rita Humeniuk, Anita Mathias,[...]. Jpn J Clin Oncol 2020
2
100

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.
Grainne M O'Kane, Éanna Ryan, Terri P McVeigh, Ben Creavin, John Mp Hyland, Diarmuid P O'Donoghue, Denise Keegan, Robert Geraghty, Delia Flannery, Carmel Nolan,[...]. Cancer Med 2017
19
100

EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
Marjolijn J L Ligtenberg, Roland P Kuiper, Ad Geurts van Kessel, Nicoline Hoogerbrugge. Fam Cancer 2013
70
100

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
100

Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Anne M Mills, Emily A Sloan, Martha Thomas, Susan C Modesitt, Mark H Stoler, Kristen A Atkins, Christopher A Moskaluk. Am J Surg Pathol 2016
48
100

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
Andrea E de Jong, Marjo van Puijenbroek, Yvonne Hendriks, Carli Tops, Juul Wijnen, Margreet G E M Ausems, Hanne Meijers-Heijboer, Anja Wagner, Theo A M van Os, Annette H J T Bröcker-Vriends,[...]. Clin Cancer Res 2004
178
100

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
R S van der Post, L A Kiemeney, M J L Ligtenberg, J A Witjes, C A Hulsbergen-van de Kaa, D Bodmer, L Schaap, C M Kets, J H J M van Krieken, N Hoogerbrugge. J Med Genet 2010
115
100

Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Patrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, Mats Jönsson, Mef Nilbert. Urology 2015
44
100

Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Shinji Urakami, Naoko Inoshita, Suguru Oka, Yu Miyama, Sachio Nomura, Masami Arai, Kazushige Sakaguchi, Kazuhiro Kurosawa, Toshikazu Okaneya. Int J Urol 2018
16
100

Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder.
A A Saetta, A Goudopoulou, P Korkolopoulou, G Voutsinas, E Thomas-Tsagli, N V Michalopoulos, E Patsouris. Eur J Surg Oncol 2004
14
100

Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
Tomer Adar, Linda H Rodgers, Kristen M Shannon, Makoto Yoshida, Tianle Ma, Anthony Mattia, Gregory Y Lauwers, Anthony J Iafrate, Nicole M Hartford, Esther Oliva,[...]. Cancer 2018
43
100

Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.
Johannes Giedl, Roland Schneckenpointner, Thomas Filbeck, Petra Ruemmele, Ferdinand Hofstaedter, Maximilian Burger, Arndt Hartmann, Robert Stoehr. Am J Clin Pathol 2014
17
100

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Alicia Latham, Preethi Srinivasan, Yelena Kemel, Jinru Shia, Chaitanya Bandlamudi, Diana Mandelker, Sumit Middha, Jaclyn Hechtman, Ahmet Zehir, Marianne Dubard-Gault,[...]. J Clin Oncol 2019
152
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.